Emphasis on Type (Expanded Carrier Screening and Targeted Disease Carrier Screening); Medical Condition (Cystic Fibrosis, Tay Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy, and Others); Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others); End-Users (Hospitals, Laboratories, Clinics, and Others); Region (North America, Europe, Asia-Pacific, Rest of the World); and Region/Country
The global carrier screening market is expected to grow at a significant rate of around 15% during the forecast period. Genetic screening is a tool used to identify individuals who are at a higher risk of developing a particular disorder or who carry a specific gene for a disorder. It is a type of genetic testing, used to identify changes in an individual’s genetic material, such as their chromosomes, genes, or proteins. Genetic disorders are permanent in nature or have expensive treatment that results in the rising demand for carrier screening tests. Furthermore, the increasing investment in research and development is also an important factor catalyzing the market’s growth. For instance, according to the congressional research service, since 2000, total global R&D expenditures have more than tripled in current dollars, from USD 675 billion to USD 2.4 trillion in 2020.
Myriad Genetics, Inc.; Cepheid; Illumina, Inc; Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Laboratory Corporation of America Holdings; Otogenetics; T MedGenome; Genentech, Inc; and CENTOGENE N.V. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst Type, expanded carrier screening category to grow with the highest CAGR during the forecast period.”
Based on the type, the market has been categorized into expanded carrier screening and targeted disease carrier screening. Among them, the expanded carrier screening category to grow with the highest CAGR during the forecast period. Expanded carrier screening refers to reproductive genetic carrier screening beyond one’s ethnicity and family history. Due to the ability of the technique to read more than 100 genes at a time and the examination of multiple genetic disorders, the segment is expected to witness fast growth during the forecast period.
“Amongst Medical Conditions, cystic fibrosis segment to grow at a fast rate during the forecast period”
Based on the medical condition, the market has been categorized into cystic fibrosis, Tay Sachs, Gaucher disease, sickle cell disease, spinal muscular atrophy, and others. Among them, the cystic fibrosis segment will grow fast during the forecast period. The increasing prevalence of the disease is the main reason for the rapid growth of the segment. For instance, as per the American Lung Association, there are about 30,000 people with cystic fibrosis in the United States and approximately 70,000 people worldwide.
“Amongst End-users, clinics segment to hold a higher CAGR during the forecast period”
Based on the end-users, the market has been categorized into hospitals, laboratories, clinics, and others. Among them, the clinics segment holds a higher CAGR during the forecast period. The increasing number of private clinicians along with the increasing governmental effort in the development of local clinics for better access to healthcare facilities attributes to the significant growth of the segment in the carrier screening market.
“Asia Pacific to witness the fastest growth in the market”
Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The major factors such as the presence of emerging economies, frequent product launches, and governmental policies to support child and maternal health responsible for the market growth in the region. For instance, in August 2020, Dr Harsh Vardhan, Union Minister of Health & Family Welfare inaugurated a Thalassemia Screening and Counselling Centre at the Indian Red Cross Society’s National Headquarters Blood Bank.
Reasons to buy this report:
Customization Options:
The global Carrier Screening market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Carrier Screening Market
6. Carrier Screening Market Revenue (usd Bn), 2020-2028f
7. Market Insights By Type
8. Market Insights By Medical Condition
9. Market Insights By Technology
10. Market Insights By End-user
11. Market Insights By Region
12. Carrier Screening Market Dynamics
13. Carrier Screening Market Opportunities
14. Carrier Screening Market Trends
15. Demand And Supply-side Analysis
16. Value Chain Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Carrier Screening Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global carrier screening market were the three major steps undertaken to create and analyze the adoption of carrier screening in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global carrier screening market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the carrier screening market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the carrier screening market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, medical condition, technology, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the carrier screening market. Further, we conducted factor analysis using dependent and independent variables such as the type, medical condition, technology, and end-users of Carrier Screening. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Carrier Screening market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global carrier screening market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global carrier screening market. Data was split into several segments & sub-segments post studying various parameters and trends in the type, medical condition, technology, and end-users in the global carrier screening market.
The main objective of the Global Carrier Screening Market Study
The current & future market trends of the global carrier screening market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
